About this Journal Submit a Manuscript Table of Contents
ISRN Immunology
Volume 2012 (2012), Article ID 530179, 9 pages
http://dx.doi.org/10.5402/2012/530179
Clinical Study

Resection and Immunotherapy for Recurrent Grade III Glioma

1Department of Child & Women, University Hospital Leuven, Catholic University of Leuven, 3000 Leuven, Belgium
2Department of Neurosurgery, University Hospital Leuven, Catholic University of Leuven, 3000 Leuven, Belgium
3Department of Experimental Medicine, University Hospital Leuven, Catholic University of Leuven, 3000 Leuven, Belgium
4Pediatric Hemato-Oncology, University Hospital Leuven, Herestraat 49, 3000 Leuven, Belgium

Received 27 September 2011; Accepted 10 November 2011

Academic Editors: A. Rebollo and S. Vuckovic

Copyright © 2012 Iris Elens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Stefaan van Gool, “Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials,” Immunotherapy, vol. 5, no. 10, pp. 1043–1046, 2013. View at Publisher · View at Google Scholar
  • Lien Vandenberk, Abhishek D. Garg, Tina Verschuere, Carolien Koks, Jochen Belmans, Monique Beullens, Patrizia Agostinis, Steven De Vleeschouwer, and Stefaan W. Van Gool, “Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma,” OncoImmunology, vol. 5, no. 2, pp. e1083669, 2015. View at Publisher · View at Google Scholar
  • Lien Vandenberk, Jochen Belmans, Matthias Van Woensel, Matteo Riva, and Stefaan W. Van Gool, “Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines,” Frontiers in Immunology, vol. 6, 2016. View at Publisher · View at Google Scholar